Latest Period
Q2 2026
Security Snapshot
Biofrontera Inc. - Common Shares (BFRI) Institutional Ownership
CUSIP: 09077D209
13F Institutional Holders and Ownership History from Q3 2023 to Q2 2026
Institutions Reporting
19
Shares (Excl. Options)
2,761,510
Price
$0.95
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Shares
- Symbol
- BFRI on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 2,761,510
- Total 13F value
- $2,609,879
- Portfolio coverage rank
- 0%
- Share change
- +369,516
- Value change
- +$355,069
- Number of holders
- 19
- Shares outstanding
- 169,713,424
- SEC-reported price per share
- $1.14
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BFRI - Biofrontera Inc. - Common Shares is tracked under CUSIP 09077D209.
- 19 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 12 to 19 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $1,935,125 to $2,609,879.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 19 institutions filings for Q2 2026.
Security key
09077D209
Latest holder period
Q2 2026
13F holders
19
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
BFRI full holder history
Biofrontera Inc. SEC filings
Biofrontera Inc. company facts
Biofrontera Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 09077D209:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
BFRI
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Rosalind Advisors, Inc. | 9.9% | 0% | $19,153,857 | +$698,647 | 16,801,629 | +3.8% | Rosalind Advisors, Inc. | 30 Jun 2026 |
| DEUTSCHE BALATON AKTIENGESELLSCHAFT | 20% | +303% | $2,194,918 | +$1,800,278 | 2,552,230 | +456% | Deutsche Balaton Aktiengesellschaft | 16 Sep 2025 |
| HIRSCHMAN ORIN | 7.9% | -20% | $741,320 | +$24,824 | 915,210 | +3.5% | Orin Hirschman | 31 Dec 2025 |
| LYTTON LAURENCE W | 3.5% | $254,561 | 306,700 | LYTTON LAURENCE W | 31 Mar 2025 |
As of 30 Jun 2026, 19 institutional investors reported holding 2,761,510 shares of Biofrontera Inc. - Common Shares (BFRI). This represents 1.6% of the company’s total 169,713,424 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
12
Latest
Q2 2026
Rows shown
1-12 of 12
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 2,761,510 | $2,609,879 | +$355,069 | $0.95 | 19 |
| 2026 Q1 | 2,391,994 | $1,935,125 | +$45,366 | $0.81 | 12 |
| 2025 Q4 | 2,337,780 | $1,332,536 | -$58,124 | $0.57 | 13 |
| 2025 Q3 | 2,424,072 | $2,387,496 | +$385,700 | $0.98 | 13 |
| 2025 Q2 | 2,042,591 | $1,452,354 | +$396,101 | $0.71 | 10 |
| 2025 Q1 | 1,480,010 | $1,184,228 | -$288,687 | $0.80 | 12 |
| 2024 Q4 | 1,809,292 | $1,972,058 | +$802,563 | $1.09 | 14 |
| 2024 Q3 | 1,072,623 | $1,426,592 | -$128,222 | $1.33 | 9 |
| 2024 Q2 | 1,169,064 | $1,049,824 | +$53,639 | $0.90 | 11 |
| 2024 Q1 | 1,085,850 | $1,666,079 | +$1,650,257 | $1.54 | 10 |
| 2023 Q4 | 9,447 | $26,165 | -$84,418 | $2.77 | 7 |
| 2023 Q3 | 16,193 | $142,012 | +$142,012 | $8.80 | 6 |